HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shark cartilage monograph

This article was originally published in The Tan Sheet

Executive Summary

Institute of Medicine is requesting written comments on 1draft prototype monograph for shark cartilage by Oct. 6. Committee on the Framework for Evaluating the Safety of Dietary Supplements and its consultants will meet Oct. 7-8 to consider comments. Monograph, which was released Sept. 18, includes a description of dietary supplement preparations, amount ingested in ordinary use, human safety data, animal studies, sources of potential contamination and conditions of use suggested or recommended in labeling. IoM released a draft monograph on chaparral in August (2"The Tan Sheet" Sept. 9, 2002, p. 8). Committee also is scheduled to hold a public meeting Sept. 26 in Washington, D.C...
Advertisement

Related Content

Chaparral AER Data Resembles Kava Reports, CRN’s Cardellina Says
Chaparral AER Data Resembles Kava Reports, CRN’s Cardellina Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS094566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel